Braak stage 1, 100% of pigmented neurons left
parkinsonconnecting

Gene record

BIN1

bridging integrator 1

translation score 0.53, read 2026-10-22; 2 sealed predictions, 0 held; 3 receipts.

Six readers

readerfoundscore
genetics
Open Targets
no genetic evidence; overall 0.03 from other evidence0.00
cell type
Human Protein Atlas
cell type enhanced, including oligodendrocytes; strongest in thymic myoid cells0.75
chemistry
Open Targets
a small-molecule pocket0.60
trials
ClinicalTrials.gov
no Parkinson's trials on record: an open field1.00
literature
PubMed
27 Parkinson's papers of 7580.56
pathways
Reactome
1 pathway; mostly vesicle traffic1.00

No case: the score is under the bar. Receipt 6343

Sealed predictions

  1. BIN1 in oligodendrocytes, braak-0.03 (p 0.944) → -0.29 (p 0.456)receipt 6350
  2. BIN1 in dopamine neurons, braak-0.15 (p 0.705) → -0.75 (p 0.020)receipt 6351

Swarm cases

receipt 6351: BIN1 in dopamine neurons, braak

power
full sample -0.40 (p 0.103, n 18), 95% CI -0.73 to +0.09. the interval is wide: not enough donors to tell.
confounder
adjusted for sex: -0.46 (p 0.055, n 18). does not hold up.
composition
dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.46 (p 0.057, n 18). could be the mix.
skeptic
leave-one-out range -0.54 to -0.31, sign flips 0; without severely affected donors -0.40 (p 0.103, n 18). fragile.
cell type
no other cell group does better.
axis
no measure beats "tracks Braak Lewy-body stage" for BIN1 in dopamine neurons.

case closed: nothing better to follow up.

receipt 6350: BIN1 in oligodendrocytes, braak

power
full sample -0.23 (p 0.355, n 18), 95% CI -0.63 to +0.26. the interval is wide: not enough donors to tell.
confounder
adjusted for sex: -0.21 (p 0.398, n 18). does not hold up.
composition
oligodendrocytes share of nuclei vs axis +0.03 (p 0.915); controlling for it: -0.22 (p 0.374, n 18). could be the mix.
skeptic
leave-one-out range -0.42 to -0.13, sign flips 0; without severely affected donors -0.23 (p 0.355, n 18). fragile.
cell type
no other cell group does better.
axis
no measure beats "tracks Braak Lewy-body stage" for BIN1 in oligodendrocytes.

case closed: nothing better to follow up.

Receipts

loading the receipts